Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status
Open Access
- 1 December 2015
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA Dermatology
- Vol. 151 (12) , 1301-1307
Abstract
Histologic regression in melanoma is defined as an area within the tumor in which neoplastic cells have disappeared or become reduced in number from the dermis (and occasionally from the epidermis) and have been substituted by fibrosis with accompanying melanophages, new vessels, and a variable inflammatory infiltrate.1,2 Regression is found in melanoma with a frequency that ranges from 10% to 35%.3 The prognostic significance of regression in primary melanoma has been debated for many years.4 The potential poor prognosis associated with regression is that the disappearance of a portion of the tumor may lead to an underestimation of the original Breslow thickness. It is therefore difficult to accurately assess prognosis and also whether sentinel lymph node biopsy (SLNB) should be used to assess thickness, since it might no longer be accurate.5-8Keywords
This publication has 33 references indexed in Scilit:
- Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in MelanomaNew England Journal of Medicine, 2014
- Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patientsBritish Journal of Dermatology, 2013
- Sentinel lymph node biopsy for melanoma is becoming a consensus: a national survey of French centres involved in melanoma care in 2008Journal of the European Academy of Dermatology and Venereology, 2011
- Factors Predictive of the Status of Sentinel Lymph Nodes in Melanoma Patients from a Large Multicenter DatabaseAnnals of Surgical Oncology, 2011
- Histological regression in primary melanoma: not a predictor of sentinel lymph node metastasis in a cohort of 397 patientsBritish Journal of Dermatology, 2009
- The correlation of regression in primary melanoma with sentinel lymph node statusJournal of Clinical Pathology, 2007
- Sentinel Node Biopsy for Early-Stage Melanoma: Accuracy and Morbidity in MSLT-I, an International Multicenter TrialYearbook of Dermatology and Dermatologic Surgery, 2006
- Histologic regression in malignant melanoma: an interobserver concordance studyJournal of Cutaneous Pathology, 1993
- Histological regression in primary cutaneous melanoma: recognition, prevalence and significanceHistopathology, 1992
- Thin regressing malignant melanoma: Significance of concurrent regional lymph node metastasesHistopathology, 1989